within Pharmacolibrary.Drugs.N_NervousSystem.N02B_OtherAnalgesicsAndAntipyretics.N02BA12_PotassiumSalicylate;

model PotassiumSalicylate
  extends Pharmacolibrary.Drugs.ATC.N.N02BA12;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>N02BA12</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Potassium salicylate is a salt of salicylic acid with analgesic, antipyretic, and anti-inflammatory properties. Historically, it was used for pain and fever relief. It is not commonly used or approved in modern clinical practice due to the availability of other salicylates and safer alternatives.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters for a typical healthy adult, based on properties of salicylates (notably sodium salicylate and acetylsalicylic acid), as no direct clinical PK studies for potassium salicylate found in available sources.</p><h4>References</h4><ol><li><p> (2003). Safety assessment of Salicylic Acid, Butyloctyl Salicylate, Calcium Salicylate, C12-15 Alkyl Salicylate, Capryloyl Salicylic Acid, Hexyldodecyl Salicylate, Isocetyl Salicylate, Isodecyl Salicylate, Magnesium Salicylate, MEA-Salicylate, Ethylhexyl Salicylate, Potassium Salicylate, Methyl Salicylate, Myristyl Salicylate, Sodium Salicylate, TEA-Salicylate, and Tridecyl Salicylate. <i>International journal of toxicology</i> 22 Suppl 3 1–108. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/14617432/&quot;>https://pubmed.ncbi.nlm.nih.gov/14617432</a></p></li><li><p>Chen, J, et al., &amp; Xie, F (2018). Starch film-coated microparticles for oral colon-specific drug delivery. <i>Carbohydrate polymers</i> 191 242–254. DOI:<a href=&quot;https://doi.org/10.1016/j.carbpol.2018.03.025&quot;>10.1016/j.carbpol.2018.03.025</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/29661315/&quot;>https://pubmed.ncbi.nlm.nih.gov/29661315</a></p></li><li><p>Bae, SK, et al., &amp; Shin, JG (2008). Determination of acetylsalicylic acid and its major metabolite, salicylic acid, in human plasma using liquid chromatography-tandem mass spectrometry: application to pharmacokinetic study of Astrix in Korean healthy volunteers. <i>Biomedical chromatography : BMC</i> 22(6) 590–595. DOI:<a href=&quot;https://doi.org/10.1002/bmc.973&quot;>10.1002/bmc.973</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/18254152/&quot;>https://pubmed.ncbi.nlm.nih.gov/18254152</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end PotassiumSalicylate;
